Literature DB >> 9806925

Functional and biochemical interactions of Wnts with FrzA, a secreted Wnt antagonist.

Q Xu1, P A D'Amore, S Y Sokol.   

Abstract

Wnts are highly conserved developmental regulators that mediate inductive signaling between neighboring cells and participate in the determination of embryonic axes. Frizzled proteins constitute a large family of putative transmembrane receptors for Wnt signals. FrzA is a novel protein that shares sequence similarity with the extracellular domain of Frizzled. The Xenopus homologue of FrzA is dynamically regulated during early development. At the neurula stages, XfrzA mRNA is abundant in the somitic mesoderm, but later becomes strongly expressed in developing heart, neural crest derivatives, endoderm, otic vesicle and other sites of organogenesis. To evaluate possible biological functions of FrzA, we analyzed its effect on early Xenopus development. Microinjection of bovine or Xenopus FrzA mRNA into dorsal blastomeres resulted in a shortened body axis, suggesting a block of convergent extension movements. Consistent with this possibility, FrzA blocked elongation of ectodermal explants in response to activin, a potent mesoderm-inducing factor. FrzA inhibited induction of secondary axes by Xwnt8 and human Wnt2, but not by Xdsh, supporting the idea that FrzA interferes with Wnt signaling. Furthermore, FrzA suppressed Wnt-dependent activation of the early response genes in ectodermal explants and in the marginal zone. Finally, immunoprecipitation experiments demonstrate that FrzA binds to the soluble Wingless protein in cell culture supernatants in vitro. Our results indicate that FrzA is a naturally occurring secreted antagonist of Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806925     DOI: 10.1242/dev.125.23.4767

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  21 in total

1.  Inhibition of Wnt activity induces heart formation from posterior mesoderm.

Authors:  M J Marvin; G Di Rocco; A Gardiner; S M Bush; A B Lassar
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Axis determination by inhibition of Wnt signaling in Xenopus.

Authors:  K Itoh; S Y Sokol
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

3.  SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.

Authors:  Julianna Kele; Emma R Andersson; J Carlos Villaescusa; Lukas Cajanek; Clare L Parish; Sonia Bonilla; Enrique M Toledo; Vitezslav Bryja; Jeffrey S Rubin; Akihiko Shimono; Ernest Arenas
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

Review 4.  Wnt pathway antagonists and angiogenesis.

Authors:  Bin Zhang; Jian-Xing Ma
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

Review 5.  Winding through the WNT pathway during cellular development and demise.

Authors:  F Li; Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2006-01       Impact factor: 2.303

6.  Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3.

Authors:  Lisa M Galli; Tiffany Barnes; Tina Cheng; Lisa Acosta; Adolph Anglade; Karl Willert; Roel Nusse; Laura W Burrus
Journal:  Dev Dyn       Date:  2006-03       Impact factor: 3.780

7.  Wnt antagonism initiates cardiogenesis in Xenopus laevis.

Authors:  V A Schneider; M Mercola
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

8.  Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity.

Authors:  Mei Ding; Xin Wang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

9.  Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins.

Authors:  Barbara K Brott; Sergei Y Sokol
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  sfrp1 promotes cardiomyocyte differentiation in Xenopus via negative-feedback regulation of Wnt signalling.

Authors:  Natalie Gibb; Danielle L Lavery; Stefan Hoppler
Journal:  Development       Date:  2013-04       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.